Benefits and Risks of Sex Hormone Replacement in Postmenopausal Women

REFERENCES

• Unsigned: The Women’s Health Initiative Study Group. Design of the Women’ Health Initiative Clinical Trial and Observational Study.Controlled Clin Trials19 :61– 109,1998 .
   PubMedGoogle Scholar
• Rossouw JE: Hormone replacement therapy and cardiovascular disease.Curr Opin Lipidol10 :429– 434,1999 .
   PubMedGoogle Scholar
• Rossouw JE, Anderson GL, Prentice RL et al: Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial.JAMA288 :321– 333,2002 .
   PubMed Web of Science ®Google Scholar
• Anderson TW: The changing pattern of ischemic heart disease.Canad Med Assoc J108 :1500– 1504,1973 .
   PubMed Web of Science ®Google Scholar
• Anderson TW, LeRiche W: Ischemic heart disease and sudden death, 901–1961.Brit J Prev Soc Med24 :1– 9,1970 .
   PubMedGoogle Scholar
• Stamler JS: The relationship of sex and gonadal hormones to atherosclerosis. In Sandler M, Boume GH (eds):“Atherosclerosis and Its Origin.” New York: Academic Press, pp231– 262,1963 .
   Google Scholar
• Kalin MF, Zumoff B: Sex hormones and coronary disease: a review of the clinical studies.Steroids55(8) :330– 352,1990 .
   Google Scholar
• Unsigned: The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group.JAMA226 :652– 657,1973 .
   PubMedGoogle Scholar
• Blackard CE, Doe RP, Mellinger GT, Byar D: Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.Cancer26 :249– 256,1970 .
   PubMed Web of Science ®Google Scholar
• Byar DP, Corle DK: Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies.NCI Monogr7 :165– 170,1988 .
   PubMedGoogle Scholar
• Nilsson IM, Kullander S: Coagulation and fibrinolytic studies during use of gestogens.Acta Obst Gynec Scand46 :286– 303,1967 .
   PubMed Web of Science ®Google Scholar
• Anderson TW: Oral contraceptives and female mortality trends.Canad Med Assoc J102 :1156– 1160,1970 .
   PubMedGoogle Scholar
• Bottiger LE, Westerholm B: Oral contraceptives and thromboembolic disease.Acta Med Scand190 :455– 463,1971 .
   PubMedGoogle Scholar
• Bruckert E, Turpin G: Estrogens and progestins in postmenopausal women; influence on lipid parameters and cardiovascular risk.Horm Res43 :100– 103,1995 .
   PubMedGoogle Scholar
• McGrath BP, Liang YL, Teede H, et al: Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy.Arterioscler Thromb Vasc Biol J18 :1149– 1156,1998 .
   PubMed Web of Science ®Google Scholar
• Scuteri A, Lakatta EG, Bos AJ, Fleg JL: Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women.Aging (Milano)13 :122– 130,2001 .
   PubMedGoogle Scholar
• Cushman M: Effects of hormone replace therapy and estrogen receptor modulators on markers of inflammation and coagulation.Am J Cardiol90 :7F– 10F,2002 .
   PubMed Web of Science ®Google Scholar
• Luyer MD, Khosla S, Owen WG, Miller VM: Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women.J Clin Endocrinol Metab86(8) :3629– 3634,2001 .
   Google Scholar
• Kuttenn F, Gerson M, de Ligneres B: [Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study] [LA: French]Presse Med31 :468– 475,2002 .
   PubMedGoogle Scholar
• Cano A, Van Baal WM: The mechanisms of thrombotic risk induced by hormone replacement therapy.Maturitas40 :17– 38,2001 .
   PubMed Web of Science ®Google Scholar
• Bracamont MP, Miller VM: Vascular effects of estrogens: arterial protection versus venous thrombotic risk.Trend Endocrinol Metab12 :204– 209,2001 .
   PubMedGoogle Scholar
• DeJorge FB, Canato C, Medici C, Delascio D: Effects of the progestin-estrogen oral contraceptives on blood serum copper, copper oxidase, magnesium and sulphur concentrations.Matern Infanc26 :261– 267,1967 .
   Google Scholar
• Cohen L, Laor A, Kitzes R: Bone magnesium, crystallinity index and state of body magnesium in subjects with senile osteoporosis, maturity-onset diabetes and women treated with contraceptive preparations.Magnesium2 :70– 75,1983 .
   Google Scholar
• Goldsmith NF, Johnston JO: Magnesium-estrogen hypothesis: thromboembolic and mineralization ratios. In (M Cantin, MS Seelig, eds)Magnesium in Health & Disease. Spectrum, New York. p313– 323,1980 .
   Google Scholar
• Blum M, Kitai E, Ariel Y, et al: [Oral contraceptive lowers serum magnesium] (LA: Hebrew)Harefuah121 :363– 364,1991 .
   PubMedGoogle Scholar
• Durlach J: [The pill and thrombosis (platelets, estrogens and magnesium)]. [LA: French]Rev Franc Endocr Clin11 :45– 54,1970 .
   PubMedGoogle Scholar
• Seelig MS: Increased need for magnesium with the use of combined oestrogen and calcium for osteoporosis treatment.Magnes Res3 :197– 215,1990 .
   PubMedGoogle Scholar
• Seelig MS: Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome.J Am Coll Nutr12 :442– 458,1993 .
   PubMed Web of Science ®Google Scholar
• Muneyvirci-Delale O, Nacharaju VL, Altura BM, Altura BT: Sex steroid hormones modulate serum ionized magnesium and calcium levels throughout the menstrual cycle in women.Fertil Steril69 :958– 962,1998 .
   PubMed Web of Science ®Google Scholar
• Muneyyirci-Delale O, Nacharaju VL, Dalloul M, Altura BM, Altura BT: Serum ionized magnesium and calcium in women after menopause: inverse relation of estrogen with ionized magnesium.Fertil Steril71 :869– 872,1999 .
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy A, Muneyyirci-Delale O, Nacharaju VL, Dalloul M, Altura BM, Altura BT: Circulating divalent cations in asymptomatic ovarian hyperstimulation and in vitro fertilization patients.Gynecol Obstet Invest52 :237– 242,2001 .
   PubMedGoogle Scholar
• Seelig MS: The requirement of magnesium by the normal adult.Am J Clin Nutr14 :342– 390,1964 .
   Web of Science ®Google Scholar
• Hathaway M: Magnesium in human nutrition. Home Econ Res Rep 19. Agric Res Serv, USDA Washington, DC, p1– 94,1962 .
   Google Scholar
• Seelig MS: Epidemiologic data on magnesium deficiency-associated cardiovascular disease and osteoporosis; consideration of risks of current recommendations for high calcium intake.In Advances in Magnesium Research: Nutrition and Health , Ed Y Rayssiguier, Chapt 27, p177– 190,2001 .
   Google Scholar
• Food & Nutrition Board, Inst of Medicine.Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC, Natl Acad Press,1997 .
   Google Scholar
• Seelig MS, Lehr D:Effects of estrogen on tissue magnesium content possible influence on cardiovascular and bone disease. In (J. Durlach, ed) 1st International Symposium on Magnesium Deficit. Vittel, May 1971: 9–15, p249– 255,1973 .
   Google Scholar
• Seelig MS: Myocardial loss of functional magnesium. I. Effect on mitochondrial integrity and potassium retention; II. In cardiomyopathies of different etiology. In“Recent Advances in Studies on Cardiac Structure and Metabolism” 1, Eds E Bajusz & G Rona, 615–625;626– 638,1972 .
   Google Scholar
• Seelig MS, Heggtveit HA: Magnesium interrelationships in ischemic heart disease: a review.Am J Clin Nutr27 :59– 79,1974 .
   PubMed Web of Science ®Google Scholar
• Seelig MS, Haddy FJ:Magnesium and the Arteries: I. Effects of magnesium deficiency on arteries and on retention of sodium, potassium, and calcium. In Magnesium in Health and Disease, Eds M Cantin, MS Seelig, Publ Spectrum Press, NY, p605– 638,1980 .
   Google Scholar
• Haddy FJ, Seelig MS:Magnesium and the arteries: II. Physiologic effects of electrolyte abnormalities on arterial resistance. Ibid, 1980 pp639– 657,1980 .
   Google Scholar
• Sheehan JP, Seelig MS: Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease.Magnesium3 :301– 314,1984 .
   PubMedGoogle Scholar
• Seelig MS: Nutritional status and requirements of magnesium, with consideration of individual differences and prevention of cardiovascular disease.Magnesium Bull8 :170– 185,1986 .
   Google Scholar
• Seelig MS: Cardiovascular consequences of magnesium deficiency and loss; pathogenesis, prevalence and manifestations—magnesium and chloride loss in refractory potassium repletion.Am J Cardiology63 :4G– 21G,1989 .
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Borella P, Valentini M, Fioroni L, Genazzani AR: Premenstrual increase of intracellular magnesium levels in women with ovulatory, asymptomatic menstrual cycles.Gynecol Endocrinol2 :249– 256,1988 .
   PubMed Web of Science ®Google Scholar
• Malkiel-Shapiro B, Bershon I, Terner PE: Parenteral magnesium sulphate therapy in coronary heart disease. A preliminary report on its clinical and laboratory aspects.Med Proc2 :455– 462,1956 .
   Google Scholar
• Parsons RS, Butler TC, Sellars EP: The treatment of coronary artery disease.Med Proc5 :487– 498,1959 .
   Google Scholar
• Davis WH, Leary WP, Reyes AJ, Olhaberry JV: Monotherapy with magnesium increases abnormally low high density lipoprotein cholesterol: a clinical assay.Curr Therap Res36 :341– 344,1984 .
   Web of Science ®Google Scholar
• Rasmussen HS, Aurup P, Goldstein K, et al: Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study.Arch Int Med149 :1050– 1053,1989 .
   PubMed Web of Science ®Google Scholar
• Corica F, Allegra A, Di Benedetto A, et al: Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus.Magnes Res7 :43– 46,1994 .
   PubMedGoogle Scholar
• Haenni A, Ohrvall M, Lithell H: Atherogenic lipid fractions are related to ionized magnesium status.Am J Clin Nutr67 :202– 207,1998 .
   PubMed Web of Science ®Google Scholar
• Gueux E, Rayssiguier Y, Piot MC, Alcindor L: Reduction of plasma lecithin-cholesterol-acyl-transferase activity by acute magnesium deficiency in the rat.J Nutr114 :1479– 1483,1984 .
   PubMed Web of Science ®Google Scholar
• Rayssiguier Y, Gueux E: Magnesium and lipids in cardiovascular disease.J Am Coll Nutr5 :507– 519,1986 .
   PubMed Web of Science ®Google Scholar
• Itoh K, Kawasaka T, Nakamura M: The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects.Br J Nutr78 :737– 750,1997 .
   PubMed Web of Science ®Google Scholar
• Rosanoff A, Seelig MS: Functions and effects of magnesium compared with those of statin pharmaceuticals.JACN23 :501S– 505S,2004 . Proc 10th Intl Mg Sympos, Cairns, Australia.
   Google Scholar
• Melton LJ 3d, O’Fallon WM, Riggs BL: Secular trends in the incidence of hip fractures.Calcif Tissue Int41 :57– 64,1987 .
   PubMed Web of Science ®Google Scholar
• Melton LJ 3d: Hip fractures: a worldwide problem today and tomorrow.Bone14 Suppl 1 :S1– 8,1993 .
   Google Scholar
• Volpe SL, Taper LJ, Meacham: The relationship between boron and magnesium status and bone mineral density in the human: a review.Magnes Res6 :291– 296,1993 .
   PubMedGoogle Scholar
• Tremollieres FA, Pouilles JM, Ribot C: Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.Osteoporos Int12 :385– 390,2001 .
   PubMed Web of Science ®Google Scholar
• Neele SJ, Evertz R, De Valk-De Roo G, et al: Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women.Bone30 :599– 603,2002 .
   PubMed Web of Science ®Google Scholar
• Greendale GA, Espeland M, Slone S, Marcus R, Barrett-Connor E: Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study.Arch Intern Med Mar162 :665– 672,2002 .
   PubMed Web of Science ®Google Scholar
• Greenspan SL, Emkey RD, Bone HG, et al: Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.Ann Int Med137 :875– 883,2002 .
   PubMed Web of Science ®Google Scholar
• Beck TJ, Stone KL, Oreskovic TL, et al: Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures.J Bone Miner Res16 :2103– 2110,2001 .
   PubMedGoogle Scholar
• Dalderup LM: Role of magnesium in osteoporosis and idiopathic hypercalcemia.Voeding21 :424– 435,1960 .
   Google Scholar
• Lai CC, Singer L, Armstrong WD: Bone composition and phosphatase activity in magnesium deficiency in rats.J Bone Joint Surg57 :516– 522,1975 .
   PubMed Web of Science ®Google Scholar
• Boskey AL, Rimnac CM, Bansal M, et al: Effect of short-term hypomagnesemia on the chemical and mechanical properties of rat bone.J Orthop Res10 :774– 783,1992 .
   PubMed Web of Science ®Google Scholar
• Kenney MA, McCoy H, Williams L: Effects of magnesium deficiency on strength, mass and composition of rat femur.Calcif Tiss Int1 :44– 49,1994 .
   Google Scholar
• Landis WJ: The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix.Bone16 :533– 544,1995 .
   PubMed Web of Science ®Google Scholar
• Cohen L, Laor A, Kitzes R: Bone magnesium, crystallinity index and state of body magnesium in subjects with senile osteoporosis, maturity-onset diabetes and women treated with contraceptive preparations.Magnesium2 :70– 75,1983 .
   Google Scholar
• Toba Y, Kajita Y, Masuyama R, et al: Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats.J Nutr130 :216– 220,2000 .
   PubMed Web of Science ®Google Scholar
• Rude RK: Magnesium deficiency: a possible risk factor for osteoporosis.Natl Aspects of Osteoporosis. Chapt23 :263– 271,2001 .
   Google Scholar
• Martin HE, Wertman M: Serum potassium, magnesium and calcium levels in diabetic acidosis.J Clin Invest26 :217– 228,1947 .
   PubMed Web of Science ®Google Scholar
• Bertelloni S: The parathyroid hormone-1,25-dihydroxyvitamin D endocrine system and magnesium status in insulin-dependent diabetes mellitus: current concepts.Magnes Res5 :45– 51,1992 .
   PubMedGoogle Scholar
• De Leeuw I, Vertommen J, Abs R: The magnesium content of the trabecular bone in diabetic subjects.Biomedicine29 :16– 17,1978 .
   PubMedGoogle Scholar
• McNair P: Bone mineral metabolism in human type 1 (insulin dependent) diabetes mellitus.Dan Med Bull35 :109– 121,1988 .
   PubMedGoogle Scholar
• Cohen L, Laor A, Kitzes R: Lymphocyte and bone magnesium in alcohol-associated osteoporosis.Magnesium4 :148– 152,1985 .
   PubMedGoogle Scholar
• Abbott L, Nadler J, Rude RK: Magnesium deficiency in alcoholism: possible contribution to osteoporosis and cardiovascular disease in alcoholics.Alcohol Clin Exp Res18(5) :1076– 1082,1994 .
   Google Scholar
• Ditmar R, Steidl L: [The significance of magnesium in orthopedics. [Magnesium in osteoporosis].Acta Chir Orthop Traumatol Czech56 :143– 159,1989 .
   PubMedGoogle Scholar
• Abraham GE, Grewal H: A total dietary program emphasizing magnesium instead of calcium. Effect on the mineral density of calcaneous bone in postmenopausal women on hormonal therapy.J Reprod Med35 :503– 507,1990 .
   PubMed Web of Science ®Google Scholar
• Driessens FC: [Prevention of osteoporosis and pathological calcifications.]Ned Tijdschr Tandheelkd100 :412– 414,1993 .
   PubMedGoogle Scholar
• Stendig-Lindberg G, Tepper R, Leichter I: Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis.Magnes Res6 :155– 163,1993 .
   PubMedGoogle Scholar
• Sojka JE, Weaver CM: Magnesium supplementation and osteoporosis.Nutr Rev53 :71– 74,1995 .
   PubMed Web of Science ®Google Scholar
• Michaelsson K, Holmberg L, Mallmin H, et al: Diet and hip fracture risk: a case control study. Study Group of the Multiple Risk Survey on Swedish Women for Eating Assessment.Int J Epidemiol24 :771– 782,1995 .
   PubMed Web of Science ®Google Scholar
• Nielsen FH, Hunt CD, Mullen LM, Hunt JR: Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women.FASEB J1 :394– 397,1987 .
   PubMed Web of Science ®Google Scholar
• Schaafsma A, de Vries PJ, Saris WH: Delay of natural bone loss by higher intakes of specific minerals and vitamins.Crit Rev Food Sci Nutr41 :225– 249,2001 .
   PubMed Web of Science ®Google Scholar
• Roughead ZK, Kunkel ME: Effect of diet on bone matrix constituents.J Am Coll Nutr10 :242– 246,1991 .
   PubMed Web of Science ®Google Scholar
• Holbrook TL, Barrett-Connor E: Calcium intake: covariates and confounders.Am J Clin Nutr53 :741– 744,1991 .
   PubMed Web of Science ®Google Scholar
• Tucker KL, Hannan MT, Chen H, et al: Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women.Am J Clin Nutr69 :727– 736,1999 .
   PubMed Web of Science ®Google Scholar
• New SA, Robins SP, Campbell MK, et al: Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health?Am J Clin Nutr71 :142– 151,2000 .
   PubMed Web of Science ®Google Scholar
• Haskell SG, Richardson ED, Horwitz RI: The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature.J Clin Epidemiol50 :1249– 1264,1997 .
   PubMed Web of Science ®Google Scholar
• Yaffe K, Sawaya G, Lieberburg I, Grady D: Estrogen therapy in postmenopausal women: effects on cognitive function and dementia.JAMA279 :688– 695,1998 .
   PubMed Web of Science ®Google Scholar
• Hogervorst E, Williams J, Budge M, et al: The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.Neuroscience101 :485– 512,2000 .
   PubMed Web of Science ®Google Scholar
• Fillenbaum GG, Hanlon JT, Landerman LR, Schmader KE: Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women.Am J Epidemiol153 :137– 144,2001 .
   PubMedGoogle Scholar
• Nelson HD, Humphrey LL, Nygren P, et al: Post-menopausal hormone replacement therapy: scientific review.JAMA288 :872– 881,2002 .
   PubMed Web of Science ®Google Scholar
• Thal LJ, Thomas RG, Mulnard R, Sano M, et al: Estrogen levels do not correlate with improvement in cognition.Arch Neurol60 :209– 212,2003 .
   PubMed Web of Science ®Google Scholar
• Zec RF, Trivedi MA: Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials.Climacteric5 :122– 134,2002 .
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Reboussin BA, Espeland MA, et al: The Women’s Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia.Controlled Clin Trials19 :604– 621,1998 .
   PubMedGoogle Scholar
• Rapp SR, Espeland MA, Shumaker SA, et al: WHIMS Investigators. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial.JAMA289 :2663– 267,2003 .
   PubMed Web of Science ®Google Scholar
• Henderson VW: Estrogen, cognition, and a woman’s risk of Alzheimer’s disease.Am J Med103(3A) :11S– 18S,1997 .
   Google Scholar
• Inestrosa NC, Marzolo MP, Bonnefont AB: Cellular and molecular basis of estrogen’s neuroprotection. Potential relevance for Alzheimer’s disease.Mol Neurobiol17 :73– 86,1998 .
   PubMedGoogle Scholar
• Greene RA: Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer’s disease.Int J Fertil Womens Med45 :253– 257,2000 .
   PubMed Web of Science ®Google Scholar
• Compton J, van Amelsvoort T, Murphy D: HRT and its effect on normal ageing of the brain and dementia.Br J Clin Pharmacol52 :647– 653,2001 .
   PubMedGoogle Scholar
• Brinton RD: Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer’s disease: recent insights and remaining challenges.Learn Mem8(3) :121– 133,2001 .
   Google Scholar
• Henderson VW: Oestrogens and dementia.Novartis Found Symp230 :254– 265,2000 .
   PubMedGoogle Scholar
• Resnick SM, Maki PM: Effects of hormone replacement therapy on cognitive and brain aging.Ann N Y Acad Sci949 :203– 214,2001 .
   PubMed Web of Science ®Google Scholar
• Shepherd JE: Effects of estrogen on cognition mood, and degenerative brain diseases.J Am Pharm Assoc41 :221– 228,2001 .
   Google Scholar
• Compton J, van Amelsvoort T, Murphy D: Mood, cognition and Alzheimer’s disease.Best Pract Res Clin Obstet Gynaecol16 :357– 370,2002 .
   PubMedGoogle Scholar
• Cholerton B, Gleason CE, Baker LD, Asthana S: Estrogen and Alzheimer’s disease: the story so far.Drugs Aging19 :405– 427,2002 .
   PubMed Web of Science ®Google Scholar
• Marks SJ, Batra RR, Frishman WH: Estrogen replacement therapy for cognitive benefits: viable treatment or forgettable “senior moment”?Heart Dis4 :26– 32,2002 .
   PubMedGoogle Scholar
• Kesslak JP: Can estrogen play a significant role in the prevention of Alzheimer’s disease?J Neural Transm Suppl62 :227– 239,2002 .
   Google Scholar
• Zec RF, Trivedi MA: The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review.Neuropsychol Rev12 :65– 109,2002 .
   PubMed Web of Science ®Google Scholar
• DeKosky ST, Orgogozo JM: Alzheimer disease: diagnosis, costs, and dimensions of treatment.Alzheimer Dis Assoc Disord.Suppl 1 :S3– 7,2001 .
   Google Scholar
• Fink G, Sumner BE, Rosie R, Grace O, Quinn JP: Estrogen control of central neurotransmission: effect on mood, mental state, and memory.Cell Mol Neurobiol16 :325– 344,1996 .
   PubMed Web of Science ®Google Scholar
• Birge SJ: Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?J Am Geriatr Soc44 :865– 870,1996 .
   PubMed Web of Science ®Google Scholar
• Sherwin BB: Hormones, mood, and cognitive functioning in postmenopausal women.Obstet Gynecol87(2 Suppl) :20S– 26S,1996 .
   Google Scholar
• Rice MM, Graves AB, McCurry SM, Larson EB: Estrogen replacement therapy and cognitive function in postmenopausal women without dementia.Am J Med103 :26S– 35S,1997 .
   PubMedGoogle Scholar
• Altieri M, Bogousslavsky Jr: [Brain dysfunction in climacteric and prevention] [LA: German]Schweiz Rundsch Med Prax86(36) :1378– 1382,1997 .
   Google Scholar
• Maki P, Zonderman A, Resnick S: Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy.Am J Psychiatry158 :227– 233,2001 .
   PubMed Web of Science ®Google Scholar
• Maki PM, Resnick SM: Effects of estrogen on patterns of brain activity at rest and during cognitive activity: A review of neuroimaging studies.Neuroimage14 :789– 801,2001 .
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Janowsky J, Chan BK, Nelson HD: Hormone replacement therapy and cognition: systematic review and meta-analysis.JAMA285 :1489– 1499,2001 .
   PubMed Web of Science ®Google Scholar
• Carlson MC, Zandi PP, Plassman BL, et al: Cache County Study Group: Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.Neurology57 :2210– 2216,2001 .
   PubMed Web of Science ®Google Scholar
• Birge SJ, McEwen BS, Wise PM: Effects of estrogen deficiency on brain function. Implications for the treatment of postmenopausal women.Postgrad Med Spec No:11–16,2001 .
   Google Scholar
• Greene RA, Dixon W: The role of reproductive hormones in maintaining cognition.Obstet Gynecol Clin North Am29 :437– 453,2002 .
   PubMed Web of Science ®Google Scholar
• Sherwin BB: Estrogen and cognitive aging in women.Trends Pharmacol Sci23 :527– 534,2002 .
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Spinetti A, Gallo R, Bernardi F: Menopause and the central nervous system: intervention options.Maturitas31 :103– 110,1999 .
   PubMed Web of Science ®Google Scholar
• Costa MM, Reus VI, Wolkowitz OM, et al: Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women.Biol Psychiatry46 :182– 188,1999 .
   PubMed Web of Science ®Google Scholar
• Farrag AK, Khedr EM, Abdel-Aleem H, Rageh TA: Effect of surgical menopause on cognitive functions.Dement Geriatr Cogn Disord13 :193– 198,2002 .
   PubMed Web of Science ®Google Scholar
• Kritz-Silverstein D, Barrett-Connor E: Hysterectomy, oophorectomy, and cognitive function in older women.J Am Geriatr Soc50 :55– 61,2002 .
   PubMed Web of Science ®Google Scholar
• Silva I, Mor G, Naftolin F: Estrogen and the aging brain.Maturitas8 :95– 100,2001 .
   Google Scholar
• Badimon L, Bayes-Genis A: Effects of progestogens on thrombosis and atherosclerosis.Hum Reprod Update5 :191– 199,1999 .
   PubMed Web of Science ®Google Scholar
• Schved JF, Biron C: [Progestogens, progesterone, coagulation and vascular tone.]Gynecol Obstet Fertil30 :421– 426,2002 .
   PubMedGoogle Scholar
• Maki PM, Rich JB, Rosenbaum RS: Implicit memory varies across the menstrual cycle: estrogen effects in young women.Neuropsychologia40 :518– 529,2002 .
   PubMed Web of Science ®Google Scholar
• Li W, Zheng T, Altura BM, Altura BT: Sex steroid hormones exert biphasic effects on cytosolic magnesium ions in cerebral vascular smooth muscle cells: possible relationships to migraine frequency in premenstrual syndromes and stroke incidence.Brain Res Bull54 :83– 89,2001 .
   PubMedGoogle Scholar
• Altura BM (1982): Magnesium and regulation of contractility of vascular smooth muscle.Adv Microcirc11 :77– 113.
   Google Scholar
• Altura BT, Altura BM: The role of magnesium in etiology of strokes and cerebrovasospasm.Magnesium1 :277– 291,1982 .
   Google Scholar
• Altura BM, Altura BT, Gebrewold A: Alcohol-induced spasms of cerebral blood vessels: relation to cerebrovascular accidents and sudden death.Science220 :331– 333,1983 .
   PubMed Web of Science ®Google Scholar
• Altura BT, Altura BM: Interactions of Mg and K on cerebral vessels—aspects in view of stroke. Review of present status and new findings.Magnesium3 :195– 211,1984 .
   PubMedGoogle Scholar
• Altura BM, Altura BT: Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis.Cell Mol Biol Res41 :347– 359,1995 .
   PubMedGoogle Scholar
• Altura BM, Altura BT: Association of alcohol in brain injury, headaches, and stroke with brain-tissue; serum levels of ionized magnesium: review of recent findings and mechanisms of action.Alcohol19 :119– 130,1999 .
   PubMed Web of Science ®Google Scholar
• Altura BM, Altura B: Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.Microcirc Endothelium Lymphatics1 :185– 220,1984 .
   PubMedGoogle Scholar
• Altura BM, Altura BT: Magnesium-calcium interrelationships in vascular smooth muscle.Magnes Bul8 :338– 350,1986 .
   Google Scholar
• Barbour RL, Gebrewold A, Altura BT, Altura BM: Optical spectroscopy and prevention of deleterious cerebral vascular effects of ethanol by magnesium ions.Eur J Pharmacol447 :79– 86,2002 .
   PubMedGoogle Scholar
• Iseri LT, French JH: Magnesium: nature’s physiologic calcium blocker.Am Heart J108 :188– 193,1984 .
   PubMed Web of Science ®Google Scholar
• Nadler JL, Goodson S, Rude RK: Evidence that prostacyclin mediates the vascular action of magnesium in humans.Hypertension9 :379– 383,1987 .
   PubMed Web of Science ®Google Scholar
• Muir KW: New experimental and clinical data on efficacy of pharmacological magnesium infusions in cerebral infarcts.Magnes Res11 :43– 56,1998 .
   PubMed Web of Science ®Google Scholar
• Muir KW: Magnesium in stroke treatment.Postgrad Med J78 :641– 645,2002 .
   PubMedGoogle Scholar
• Paschen W: Role of calcium in neuronal cell injury: which subcellular compartment is involved?Brain Res Bull53 :409– 413,2000 .
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Friberg H, Ferrand-Drake M, Wieloch T: Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion.J Cereb Blood Flow Metab19 :736– 741,1999 .
   PubMed Web of Science ®Google Scholar
• Dubinsky JM, Levi Y: Calcium-induced activation of the mitochondrial permeability transition in hippocampal neurons.J Neurosci Res53 :728– 741,1998 .
   PubMed Web of Science ®Google Scholar
• Brustovetsky N, Brustovetsky T, Jemmerson R, Dubinsky JM: Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane.J Neurochem80 :207– 218,2002 .
   PubMed Web of Science ®Google Scholar
• Frantseva MV, Carlen PL, Perez-Velazquez JL: Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons.Free Radic Biol Med31(10) :1216– 1227,2001 .
   Google Scholar
• Barbiroli B, Iotti S, Cortelli P, et al: Low brain intracellular free magnesium in mitochondrial cytopathies.J Cereb Blood Flow Metab19 :528– 532,1999 .
   PubMedGoogle Scholar
• Parks JK, Smith TS, Trimmer PA, et al: Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro.J Neurochem76 :1050– 1056,2001 .
   PubMed Web of Science ®Google Scholar
• Blanchard BJ, Konopka G, Russell M, Ingram VM: Mechanism and prevention of neurotoxicity caused by beta amyloid peptides—relation to Alzheimers disease.Brain Res776 :40– 50,1997 .
   PubMedGoogle Scholar
• Kelliher M, Fastbom J, Cowburn RF, et al: Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer’s disease neurofibrillary and beta-amyloid pathologies.Neuroscience92 :499– 513,1999 .
   PubMedGoogle Scholar
• Reilly PL: Brain injury: the pathophysiology of the first hours. ‘Talk and Die revisited’.J Clin Neurosci8 :398– 403,2001 .
   PubMed Web of Science ®Google Scholar
• Freedman AM, Cassidy MM, Weglicki WB: Magnesium-deficient myocardium demonstrates an increased susceptibility to an in vivo oxidative stress.Magnes Res4 :185– 189,1991 .
   PubMedGoogle Scholar
• Dickens BF, Weglicki WB, Li YS, Mak T: Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells.FEBS Lett311 :187– 191,1992 .
   PubMed Web of Science ®Google Scholar
• Rayssiguier Y, Durlach J, Gueux E, et al: Magnesium and ageing. I. Experimental data: importance of oxidative damage.Magnes Res6 :369– 378,1993 .
   PubMedGoogle Scholar
• Stafford RE, Mak IT, Kramer JH, Weglicki WB: Protein oxidation in magnesium deficient rat brains and kidneys.Biochem Biophys Res Commun196 :596– 600,1993 .
   PubMed Web of Science ®Google Scholar
• Zhou Q, Olinescu RM, Kummerow FA: Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial endothelial cells.Magnes Res12 :19– 29,1999 .
   PubMed Web of Science ®Google Scholar
• Li W, Zheng T, Altura BT, Altura BM: Antioxidants prevent elevation in [Ca2+](i) induced by low extracellular magnesium in cultured canine cerebral vascular smooth muscle cells: possible relationship to Mg2+ deficiency-induced vasospasm and stroke.Brain Res Bull52 :151– 154,2000 .
   PubMedGoogle Scholar
• Altura BM, Gebrewold A, Zhang A, Altura BT: Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes.Neurosci Lett341 :189– 192,2003 .
   PubMedGoogle Scholar
• Garcia LA, DeJong SC, Martin SM, et al: Magnesium reduces free radicals in an in vivo coronary occlusion reperfusion model.J Am Coll Cardiol32 :536– 539,1998 .
   PubMed Web of Science ®Google Scholar
• Yang Y, Li Q, Ahmad F, Shuaib A: Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat.Neurosci Lett285 :119– 122,2000 .
   PubMed Web of Science ®Google Scholar
• Lin JY, Chung SY, Lin MC, Cheng FC: Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique.Life Sci71 :803– 811,2002 .
   PubMed Web of Science ®Google Scholar
• Lampl Y, Geva D, Gilad R, et al: Cerebrospinal fluid magnesium level as a prognostic factor in ischaemic stroke.J Neurol245 :584– 588,1998 .
   PubMed Web of Science ®Google Scholar
• McIntosh TK, Vink R, Yamakami I, Faden AI: Magnesium protects against neurological deficit after brain injury.Brain Res482 :252– 260,1989 .
   PubMed Web of Science ®Google Scholar
• Vink R, Heath DL, McIntosh TK: Acute d prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats.J Neurochem66 :2477– 2483,1996 .
   PubMed Web of Science ®Google Scholar
• Feldman Z, Gurevitch B, Artru AA, et al: Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome.J Neurosurg85 :131– 137,1996 .
   PubMed Web of Science ®Google Scholar
• Cernak I, Vink R: Magnesium as a regulatory cation in direct and indirect traumatic brain injury.Magnesium Res12 :223– 224,1999 .
   Google Scholar
• Bareyre FM, Saatman KE, Raghupathi R, McIntosh TK: Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats.J Neurotrauma17 :1029– 1039,2000 .
   PubMed Web of Science ®Google Scholar
• Cernak I, O’Connor C, Vink R: Activation of cyclo-oxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats.Clin Exp Pharmacol Physiol28 :922– 925,2001 .
   PubMed Web of Science ®Google Scholar
• Vink R, O’Connor CA, Nimmo AJ, Heath DL: Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats.Neurosci Lett336 :41– 44,2003 .
   PubMed Web of Science ®Google Scholar
• Polderman KH, Bloemers FW, Peerdeman SM, Girbes AR: Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury.Crit Care Med28 :2022– 2025,2000 .
   PubMed Web of Science ®Google Scholar
• Cernak I, Savic VJ, Kotur J, Prokic V, et al: Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans.J Neurotrauma17 :53– 68,2000 .
   PubMed Web of Science ®Google Scholar
• Cernak I, Savic V, Kotur J, et al: Alterations in magnesium and oxidative status during chronic emotional stress.Magnes Res13 :29– 36,2000 .
   PubMedGoogle Scholar
• Corsonello A, Pedone C, Corica F: Grup Italiano Farmacovigilanza Anziano (GIFA): Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients.Magnes Res14 :273– 282,2001 .
   PubMed Web of Science ®Google Scholar
• Seelig MS: Review and hypothesis: might patients with the chronic fatigue syndrome have latent tetany of magnesium deficiency.J Chron Fatigue Syndr4 :77– 108,1998 .
   Google Scholar